100% found this document useful (4 votes)
16K views2 pages

Clindamycin Drug Study

Download as docx, pdf, or txt
Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1/ 2

Name of Patient

G. V.

Age

43 y.o

Height

52

Diagnosis

T/C PID vs acute AP

Sex

Female

Weight

66 kg

Author

M. M. Olmillo

Website

milkv.co.vu

A/N

youre welcome J

DRUG DATA
Generic name:
Clindamycin

CLASSIFICATION
Pharmacologic:
Lincosamide
antibiotic

Trade name/s:
Cleocin, Dalacin

MECHANISM OF
ACTION

Inhibits protein
synthesis in
susceptible bacteria,
causing cell death

Patients dose:
900mg q6o
Maximum dose:
2,700mg/day

Therapeutic:
Antibiotic
Onset:
Immediate

Minimum dose:
600mg/day
Availability:
Capsules 75,
150, 300mg;
granules for oral
solution 75
mg/5ml; injection
150mg/ml,
300mg/12mL,
600mg/14mL,
900mg/16mL,
300, 600,
900mg/50mL;
topical gel 1%;
topical lotion
1%; topical
suspension 1%;
vaginal cream
2%; vaginal
suppository
100mg

Pregnancy Category
Risk: B

Peak:
Minutes
Duration:
8-12 hr
Metabolism:
hepatic, 2-3 hr
Distribution:
Crosses placenta,
enters breast milk
Excretion:
Feces, urine
Topical:
Minimal systemic
absorption

INDICATIONS

General:
> systemic
administration:
serious infections
caused by
susceptible
strains of
anaerobes,
streptococci,
staphylococci,
penumococci
> parenteral:
treatment of
septicemia
> topical
dermatologic
solution:
treatment of acne
vulgaris
> vaginal
preparation:
treatment of
bacterial
vaginosis

CONTRAINDICATI
ON

ADVERSE
EFFECTS

Contraindicated with
allergy to clindamycin,
lactation

Systemic
CNS: cardiac arrest
(with rapid IV
transfusion)

Precaution:
Use cautiously in
newborns and infants
due to benzyl alcohol
content (associated with
gasping syndrome) and
in patients with tartrazine
sensitivity or hepatic or
renal impairment

GI:
pseudomembranou
s colitis

Interactions:
> drug-drug:increased
neuromuscular blockade
with neuromuscular
blocking agents;
decreased GI absorption
with kaolin, aluminium
salts

Local: pain following


injection,
thrombophlebitis
after IV use

Hematologic:
neutropenia,
leukopenia
Hyppersensitivity:
rashes

Topical
dermatologic soln
CNS: fatigue,
headache
Dermatologic:
contact dermatitis,
dryness

Patients actual
indications:
Treatment of
serious infections
caused by
susceptible
strains of
anaerobes

GI:
pseudomembranou
s colitis, bloody
diarrhea
GU: urinary
frequency

Route:
IVTT
Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Source: 2011
Lippincotts NDG

Vaginal preparation
GU: cervicitis, vulvar
irritation
Source: 2011
Lippincotts NDG

NURSING
RESPONSIBILITIE
S

Before:
> check doctors order
> assess for allergy to clindamycin,
history of asthma or other allergies,
allergy to tartrazine
> assess history of renal impairment,
lactation, regional enteritis or
ulcerative colitis
> assess site of infection or acne,
skin color, lesions,
> take clients BP
During:
> verify patients identity
> administer the right drug with the
right dose at the right time
> state the importance and purpose
of the drug to the patient
> check the patency of the IV site
and IV line
> if hypersensitivity reaction occurs,
stop the administration immediately
After:
> regulate the IVF with the
prescribed flow rate
> monitor LFTs and renal function
tests, and blood counts
> report severe or watery diarrhea,
abdominal pain, inflamed mouth or
vagina, skin rash or lesions
> take full prescribed course of oral
drug. Do not stop taking without
notifying your health care provider
> document and record.

Source: 2011 Lippincotts Nursing


Drug Guide

You might also like